March 27, 2024
(press release)
–
Earlier today, Moderna hosted its fifth annual Vaccines Day, where our leadership shared key updates on the Company’s growing infectious disease portfolio. Members of our executive team sat down to dive into key clinical updates across Moderna’s respiratory, latent and other vaccine portfolios, as well as our financial and commercial vaccine strategy. Watch our latest IR Insights video to hear more from Stéphane Bancel, CEO, Dr. Stephen Hoge, President, Jamey Mock, CFO and Dr. Jackie Miller, SVP and Head of Development for Infectious Diseases.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
